{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:31:49Z","timestamp":1774326709422,"version":"3.50.1"},"publisher-location":"Singapore","reference-count":97,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811532610","type":"print"},{"value":"9789811532627","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-981-15-3262-7_11","type":"book-chapter","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T17:03:01Z","timestamp":1593450181000},"page":"159-176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Natural Polyphenols as Modulators of the Fibrillization of Islet Amyloid Polypeptide"],"prefix":"10.1007","author":[{"given":"Ana R.","family":"Ara\u00fajo","sequence":"first","affiliation":[]},{"given":"Rui L.","family":"Reis","sequence":"additional","affiliation":[]},{"given":"Ricardo A.","family":"Pires","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,6,30]]},"reference":[{"key":"11_CR1","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/BF00274799","volume":"30","author":"P Westermark","year":"1987","unstructured":"Westermark P, Wilander E, Westermark GT, Johnson KH (1987) Islet amyloid polypeptide-like immunoreactivity in the islet B-cells of Type-2 (non-insulin-dependent) diabetic and nondiabetic individuals. Diabetologia 30:887\u2013892","journal-title":"Diabetologia"},{"key":"11_CR2","unstructured":"WHO Regional office for Europe (2019) Data and statistics. http:\/\/www.euro.who.int\/en\/health-topics\/noncommunicable-diseases\/diabetes\/data-and-statistics. Accessed 12 Dec 2019"},{"key":"11_CR3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S1262-3636(07)70239-2","volume":"31","author":"P Valensi","year":"2005","unstructured":"Valensi P, Schwarz EH, Hall M et al (2005) Pre-diabetes essential action: a European perspective. Diabetes Metab 31:606\u2013620","journal-title":"Diabetes Metab"},{"key":"11_CR4","doi-asserted-by":"publisher","first-page":"826706","DOI":"10.1155\/2013\/826706","volume":"2013","author":"K Pillay","year":"2013","unstructured":"Pillay K, Govender P (2013) Amylin uncovered: a review on the polypeptide responsible for type II diabetes. Biomed Res Int 2013:826706","journal-title":"Biomed Res Int"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1055\/s-2007-992115","volume":"116","author":"PEH Schwarz","year":"2008","unstructured":"Schwarz PEH, Lindstr\u00f6m J, Kissimova-Scarbeck K et al (2008) The European perspective of type 2 diabetes prevention: diabetes in Europe\u00a0\u2013 prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Exp Clin Endocrinol Diabetes 116:167\u2013172","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"11_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.29245\/2572.942X\/2019\/1.1212","volume":"4","author":"J Grizzanti","year":"2019","unstructured":"Grizzanti J, Corrigan R, Servizi S et al (2019) Amylin signaling in diabetes and Alzheimer\u2019s disease: therapy or pathology? J Neurol Neuromed 4:12\u201319","journal-title":"J Neurol Neuromed"},{"key":"11_CR7","doi-asserted-by":"publisher","first-page":"e12977","DOI":"10.7554\/eLife.12977","volume":"5","author":"A Abedini","year":"2016","unstructured":"Abedini A, Plesner A, Cao P et al (2016) Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics. elife 5:e12977","journal-title":"elife"},{"key":"11_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/014572179902500310","volume":"25","author":"DF Kruger","year":"1999","unstructured":"Kruger DF, Gatcomb PM, Owen SK (1999) Clinical implications of amylin and amylin deficiency. Diabetes Educ 25:389\u2013397","journal-title":"Diabetes Educ"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0196-9781(01)00348-5","volume":"22","author":"MJ Morris","year":"2001","unstructured":"Morris MJ, Nguyen T (2001) Does neuropeptide Y contribute to the anorectic action of amylin? Peptides 22:541\u2013546","journal-title":"Peptides"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"2046327","DOI":"10.1155\/2016\/2046327","volume":"2016","author":"A Pithadia","year":"2016","unstructured":"Pithadia A, Brender JR, Fierke CA (2016) Inhibition of IAPP aggregation and toxicity by natural products and derivatives. J Diabetes Res 2016:2046327","journal-title":"J Diabetes Res"},{"key":"11_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJM200008103430607","volume":"343","author":"JWM Hoppener","year":"2000","unstructured":"Hoppener JWM, Ahren B, Lips CJM (2000) Islet amyloid and type 2 diabetes mellitus. New Engl J Med 343:411\u2013419","journal-title":"New Engl J Med"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fendo.2014.00216","volume":"5","author":"D Milardi","year":"2014","unstructured":"Milardi D, Sciacca MFM, Randazzo L et al (2014) The role of calcium, lipid membranes and islet amyloid polypeptide in the onset of type 2 diabetes: innocent bystanders or partners in a crime? Front Endocrinol 5:216","journal-title":"Front Endocrinol"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1084\/jem.5.4.397","volume":"5","author":"EL Opie","year":"1901","unstructured":"Opie EL (1901) On the relation of chronic interstitial pancreatitis to the islands of Langerhans and to diabetes mellitus. J Exp Med 5:397\u2013428","journal-title":"J Exp Med"},{"key":"11_CR14","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","volume":"93","author":"CB Verchere","year":"1996","unstructured":"Verchere CB, D\u2019Alessio DA, Palmiter RD et al (1996) Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Natl Acad Sci 93:3492\u20133496","journal-title":"Natl Acad Sci"},{"key":"11_CR15","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/368756a0","volume":"368","author":"A Lorenzo","year":"1994","unstructured":"Lorenzo A, Razzaboni B, Weir GC et al (1994) Pancreatic-islet cell toxicity of amylin associated with Type-2 diabetes-mellitus. Nature 368:756\u2013760","journal-title":"Nature"},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2353\/ajpath.2010.090532","volume":"176","author":"T Gurlo","year":"2010","unstructured":"Gurlo T, Ryazantsev S, Huang CJ et al (2010) Evidence for proteotoxicity in beta cells in Type 2 diabetes toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway. Am J Pathol 176:861\u2013869","journal-title":"Am J Pathol"},{"key":"11_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1586\/14789450.2013.841549","volume":"10","author":"F Despa","year":"2013","unstructured":"Despa F, DeCarli C (2013) Amylin: what might be its role in Alzheimer\u2019s disease and how could this affect therapy? Expert Rev Proteomics 10:403\u2013405","journal-title":"Expert Rev Proteomics"},{"key":"11_CR18","doi-asserted-by":"publisher","first-page":"16066","DOI":"10.1021\/jp409755y","volume":"117","author":"C Miller","year":"2013","unstructured":"Miller C, Zerze GH, Mittal J (2013) Molecular simulations indicate marked differences in the structure of amylin mutants, correlated with known aggregation propensity. J Phys Chem B 117:16066\u201316075","journal-title":"J Phys Chem B"},{"key":"11_CR19","doi-asserted-by":"publisher","first-page":"11338","DOI":"10.1021\/bi020314u","volume":"41","author":"M Anguiano","year":"2002","unstructured":"Anguiano M, Nowak RJ, Lansbury PT (2002) Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. Biochemistry 41:11338\u201311343","journal-title":"Biochemistry"},{"key":"11_CR20","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/cbic.201000090","volume":"11","author":"S Scalisi","year":"2010","unstructured":"Scalisi S, Sciacca MF, Zhavnerko G et al (2010) Self-assembling pathway of HiApp fibrils within lipid bilayers. Chembiochem 11:1856\u20131859","journal-title":"Chembiochem"},{"key":"11_CR21","doi-asserted-by":"publisher","first-page":"12680","DOI":"10.1021\/bi801427c","volume":"47","author":"JR Brender","year":"2008","unstructured":"Brender JR, Hartman K, Reid KR et al (2008) A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity. Biochemistry 47:12680\u201312688","journal-title":"Biochemistry"},{"key":"11_CR22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/ni.1935","volume":"11","author":"SL Masters","year":"2010","unstructured":"Masters SL, Dunne A, Subramanian SL et al (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1 beta in type 2 diabetes. Nat Immunol 11:897","journal-title":"Nat Immunol"},{"key":"11_CR23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1152\/physrev.00042.2009","volume":"91","author":"P Westermark","year":"2011","unstructured":"Westermark P, Andersson A, Westermark GT (2011) Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev 91:795\u2013826","journal-title":"Physiol Rev"},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/193229680800200619","volume":"2","author":"SM de la Monte","year":"2008","unstructured":"de la Monte SM, Wade JD (2008) Alzheimer\u2019s disease is type 3 diabetes\u00a0\u2013 evidence reviewed. J Diabetes Sci Technol 2:1101\u20131113","journal-title":"J Diabetes Sci Technol"},{"key":"11_CR25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23956","volume":"74","author":"K Jackson","year":"2013","unstructured":"Jackson K, Barisone GA, Diaz E et al (2013) Amylin deposition in the brain: a second amyloid in Alzheimer disease? Ann Neurol 74:517\u2013526","journal-title":"Ann Neurol"},{"key":"11_CR26","first-page":"146","volume":"64","author":"A Alzheimer","year":"1907","unstructured":"Alzheimer A (1907) Uber eine eigenartige Erkrankung der Hirnrinde. Zentralbl Nervenh Psych 64:146\u2013148","journal-title":"Zentralbl Nervenh Psych"},{"key":"11_CR27","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1007\/s00018-016-2295-x","volume":"73","author":"V Gupta","year":"2016","unstructured":"Gupta V, Gupta VB, Chitranshi N et al (2016) One protein, multiple pathologies: multifaceted involvement of amyloid beta in neurodegenerative disorders of the brain and retina. Cell Mol Life Sci 73:4279\u20134297","journal-title":"Cell Mol Life Sci"},{"key":"11_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nrd3050","volume":"9","author":"A Aguzzi","year":"2010","unstructured":"Aguzzi A, O\u2019Connor T (2010) Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nat Rev Drug Discov 9:237\u2013248","journal-title":"Nat Rev Drug Discov"},{"key":"11_CR29","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1006\/jmbi.2001.4593","volume":"308","author":"ETAS Jaikaran","year":"2001","unstructured":"Jaikaran ETAS, Higham CE, Serpell LC et al (2001) Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. J Mol Biol 308:515\u2013525","journal-title":"J Mol Biol"},{"key":"11_CR30","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3109\/13506120109007350","volume":"8","author":"Y Hirakura","year":"2001","unstructured":"Hirakura Y, Kagan BL (2001) Pore formation by beta-2-microglobulin: a mechanism for the pathogenesis of dialysis associated amyloidosis. Amyloid 8:94\u2013100","journal-title":"Amyloid"},{"key":"11_CR31","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4593","volume":"14","author":"YS Eisele","year":"2015","unstructured":"Eisele YS, Monteiro C, Fearns C et al (2015) Targeting protein aggregation for the treatment of degenerative diseases. Nat Rev Drug Discov 14:759\u2013780","journal-title":"Nat Rev Drug Discov"},{"key":"11_CR32","doi-asserted-by":"publisher","first-page":"10427","DOI":"10.1073\/pnas.0502066102","volume":"102","author":"A Quist","year":"2005","unstructured":"Quist A, Doudevski I, Lin H et al (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. PNAS 102:10427\u201310432","journal-title":"PNAS"},{"key":"11_CR33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nrm3542","volume":"14","author":"ET Powers","year":"2013","unstructured":"Powers ET, Balch WE (2013) Diversity in the origins of proteostasis networks\u00a0\u2013 a driver for protein function in evolution. Nat Rev Mol Cell Biol 14:237\u2013248","journal-title":"Nat Rev Mol Cell Biol"},{"key":"11_CR34","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1039\/C1CS15112F","volume":"41","author":"AS DeToma","year":"2012","unstructured":"DeToma AS, Salamekh S, Ramamoorthy A et al (2012) Misfolded proteins in Alzheimer\u2019s disease and type II diabetes. Chem Soc Rev 41:608\u2013621","journal-title":"Chem Soc Rev"},{"key":"11_CR35","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/nature02261","volume":"426","author":"CM Dobson","year":"2003","unstructured":"Dobson CM (2003) Protein folding and misfolding. Nature 426:884\u2013890","journal-title":"Nature"},{"key":"11_CR36","doi-asserted-by":"publisher","first-page":"7079","DOI":"10.1021\/ja900285z","volume":"131","author":"R Soong","year":"2009","unstructured":"Soong R, Brender JR, Macdonald PM et al (2009) Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy. ACS 131:7079\u20137085","journal-title":"ACS"},{"key":"11_CR37","doi-asserted-by":"publisher","first-page":"9900","DOI":"10.1021\/bi800828u","volume":"47","author":"IT Yonemoto","year":"2008","unstructured":"Yonemoto IT, Kroon GJA, Dyson HJ et al (2008) Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical state. Biochemistry 47:9900\u20139910","journal-title":"Biochemistry"},{"key":"11_CR38","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1023\/A:1026397008011","volume":"16","author":"AF Chaffotte","year":"1997","unstructured":"Chaffotte AF, Guijarro JI, Guillou Y et al (1997) The \u201cpre-molten globule,\u201d a new intermediate in protein folding. J Protein Chem 16:433\u2013439","journal-title":"J Protein Chem"},{"key":"11_CR39","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1073\/pnas.1209955110","volume":"110","author":"S Zhang","year":"2013","unstructured":"Zhang S, Andreasen M, Nielsen JT et al (2013) Coexistence of ribbon and helical fibrils originating from hIAPP(20-29) revealed by quantitative nanomechanical atomic force microscopy. PNAS 110:2798\u20132803","journal-title":"PNAS"},{"key":"11_CR40","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1073\/pnas.0910723107","volume":"107","author":"J Bieschke","year":"2010","unstructured":"Bieschke J, Russ J, Friedrich RP et al (2010) EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity. PNAS 107:7710\u20137715","journal-title":"PNAS"},{"key":"11_CR41","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.3390\/ijms19092677","volume":"19","author":"S Giorgetti","year":"2018","unstructured":"Giorgetti S, Greco C, Tortora P et al (2018) Targeting amyloid aggregation: an overview of strategies and mechanisms. Int J Mol Sci 19:2677","journal-title":"Int J Mol Sci"},{"key":"11_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","volume":"67","author":"Y Porat","year":"2005","unstructured":"Porat Y, Abramowitz A, Gazit E (2005) Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 67:27\u201337","journal-title":"Chem Biol Drug Des"},{"key":"11_CR43","doi-asserted-by":"publisher","first-page":"17121","DOI":"10.3390\/ijms131217121","volume":"13","author":"A Sgarbossa","year":"2012","unstructured":"Sgarbossa A (2012) Natural biomolecules and protein aggregation: emerging strategies against amyloidogenesis. Int J Mol Sci 13:17121\u201317137","journal-title":"Int J Mol Sci"},{"key":"11_CR44","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s00109-003-0464-5","volume":"81","author":"M Stefani","year":"2003","unstructured":"Stefani M, Dobson CM (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81:678\u2013699","journal-title":"J Mol Med"},{"key":"11_CR45","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/jnr.10282","volume":"69","author":"PI Moreira","year":"2002","unstructured":"Moreira PI, Santos MS, Moreno A et al (2002) Effect of amyloid beta-peptide on permeability transition pore: a comparative study. J Neurosci Res 69:257\u2013267","journal-title":"J Neurosci Res"},{"issue":"7","key":"11_CR46","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3390\/nu9070788","volume":"9","author":"IR Sequeira","year":"2017","unstructured":"Sequeira IR, Poppitt SD (2017) Unfolding novel mechanisms of polyphenol flavonoids for better glycaemic control: targeting pancreatic islet amyloid polypeptide (IAPP). Nutrients 9(7):788","journal-title":"Nutrients"},{"key":"11_CR47","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.lfs.2016.07.021","volume":"161","author":"S Molino","year":"2016","unstructured":"Molino S, Dossena M, Buonocore D et al (2016) Polyphenols in dementia: from molecular basis to clinical trials. Life Sci 161:69\u201377","journal-title":"Life Sci"},{"key":"11_CR48","doi-asserted-by":"publisher","first-page":"4860","DOI":"10.1016\/j.bbagen.2013.06.029","volume":"1830","author":"B Cheng","year":"2013","unstructured":"Cheng B, Gong H, Xiao H et al (2013) Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases. Biochim Biophys Acta 1830:4860\u20134871","journal-title":"Biochim Biophys Acta"},{"key":"11_CR49","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/anie.201000044","volume":"50","author":"S Quideau","year":"2011","unstructured":"Quideau S, Deffieux D, Douat-Casassus C et al (2011) Plant polyphenols: chemical properties, biological activities, and synthesis. Angew Chem Int Ed Eng 50:586\u2013621","journal-title":"Angew Chem Int Ed Eng"},{"key":"11_CR50","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1039\/b802662a","volume":"26","author":"A Crozier","year":"2009","unstructured":"Crozier A, Jaganath IB, Clifford MN (2009) Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 26:1001\u20131043","journal-title":"Nat Prod Rep"},{"key":"11_CR51","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2337\/dc11-2388","volume":"35","author":"AJ Cooper","year":"2012","unstructured":"Cooper AJ, Sharp SJ, Lentjes MA et al (2012) A prospective study of the association between quantity and variety of fruit and vegetable intake and incident type 2 diabetes. Diabetes Care 35:1293\u20131300","journal-title":"Diabetes Care"},{"key":"11_CR52","doi-asserted-by":"publisher","first-page":"19463","DOI":"10.1038\/srep19463","volume":"6","author":"P Nedumpully-Govindan","year":"2016","unstructured":"Nedumpully-Govindan P, Kakinen A, Pilkington EH et al (2016) Stabilizing off-pathway oligomers by polyphenol nanoassemblies for IAPP aggregation inhibition. Sci Rep 6:19463","journal-title":"Sci Rep"},{"key":"11_CR53","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/biof.1171","volume":"40","author":"M Stefani","year":"2014","unstructured":"Stefani M, Rigacci S (2014) Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation. Biofactors 40:482\u2013493","journal-title":"Biofactors"},{"key":"11_CR54","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mnfr.201400290","volume":"59","author":"VL Ngoungoure","year":"2015","unstructured":"Ngoungoure VL, Schluesener J, Moundipa PF et al (2015) Natural polyphenols binding to amyloid: a broad class of compounds to treat different human amyloid diseases. Mol Nutr Food Res 59:8\u201320","journal-title":"Mol Nutr Food Res"},{"key":"11_CR55","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jnutbio.2009.04.010","volume":"21","author":"S Rigacci","year":"2010","unstructured":"Rigacci S, Guidotti V, Bucciantini M et al (2010) Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin. J Nutr Biochem 21:726\u2013735","journal-title":"J Nutr Biochem"},{"key":"11_CR56","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bcp.2017.04.004","volume":"139","author":"P Velander","year":"2017","unstructured":"Velander P, Wu L, Henderson F et al (2017) Natural product-based amyloid inhibitors. Biochem Pharmacol 139:40\u201355","journal-title":"Biochem Pharmacol"},{"key":"11_CR57","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cofs.2016.02.002","volume":"8","author":"H Zhang","year":"2016","unstructured":"Zhang H, Tsao R (2016) Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effects. Curr Opin Food Sci 8:33\u201342","journal-title":"Curr Opin Food Sci"},{"key":"11_CR58","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1021\/bi2015162","volume":"51","author":"P Cao","year":"2012","unstructured":"Cao P, Raleigh DP (2012) Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols. Biochemistry 51:2670\u20132683","journal-title":"Biochemistry"},{"key":"11_CR59","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.1021\/bi100939a","volume":"49","author":"F Meng","year":"2010","unstructured":"Meng F, Abedini A, Plesner A et al (2010) The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity. Biochemistry 49:8127\u20138133","journal-title":"Biochemistry"},{"key":"11_CR60","doi-asserted-by":"publisher","first-page":"2046327","DOI":"10.1155\/2016\/2046327","volume":"2016","author":"A Pithadia","year":"2016","unstructured":"Pithadia A, Brender JR, Fierke CA et al (2016) Inhibition of IAPP aggregation and toxicity by natural products and derivatives. J Diabetes Res 2016:2046327","journal-title":"J Diabetes Res"},{"key":"11_CR61","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1021\/ja406831n","volume":"136","author":"LM Young","year":"2013","unstructured":"Young LM, Cao P, Raleigh DP et al (2013) Ion mobility spectrometry-mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors. J Am Chem Soc 136:660\u2013670","journal-title":"J Am Chem Soc"},{"key":"11_CR62","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.phrs.2004.06.002","volume":"51","author":"O Coskun","year":"2005","unstructured":"Coskun O, Kanter M, Korkmaz A et al (2005) Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res 51:117\u2013123","journal-title":"Pharmacol Res"},{"key":"11_CR63","first-page":"550","volume":"100","author":"P Jiang","year":"2011","unstructured":"Jiang P, Li W, Shea JE et al (2011) Resveratrol inhibits the formation of multiple-layered beta-sheet oligomers of the human islet amyloid polypeptide segment 22-27. Biophys J 100:550\u20131558","journal-title":"Biophys J"},{"key":"11_CR64","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3390\/ijms17060964","volume":"17","author":"L L\u00f3pez","year":"2016","unstructured":"L\u00f3pez L, Varea O, Navarro S et al (2016) Benzbromarone, quercetin, and folic acid inhibit amylin aggregation. Int J Mol Sci 17:964","journal-title":"Int J Mol Sci"},{"key":"11_CR65","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1096\/fj.01-0442hyp","volume":"16","author":"E Gazit","year":"2002","unstructured":"Gazit E (2002) A possible role for pi-stacking in the self-assembly of amyloid fibrils. FASEB J 16:77\u201383","journal-title":"FASEB J"},{"key":"11_CR66","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jsb.2005.06.006","volume":"151","author":"R Khurana","year":"2005","unstructured":"Khurana R, Coleman C, Lonescu-Zanetti C et al (2005) Mechanism of thioflavin T binding to amyloid fibrils. J Struct Biol 151:229\u2013238","journal-title":"J Struct Biol"},{"key":"11_CR67","first-page":"487","volume":"68","author":"PS Vassar","year":"1959","unstructured":"Vassar PS, Culling CF (1959) Fluorescent stains, with special reference to amyloid and connective tissues. Arch Pathol 68:487\u2013498","journal-title":"Arch Pathol"},{"key":"11_CR68","doi-asserted-by":"publisher","first-page":"22715","DOI":"10.1074\/jbc.M011499200","volume":"276","author":"R Khurana","year":"2001","unstructured":"Khurana R, Uversky VN, Nielsen L et al (2001) Is Congo red an amyloid-specific dye? J Biol Chem 276:22715\u201322721","journal-title":"J Biol Chem"},{"key":"11_CR69","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1021\/jacs.8b02013","volume":"140","author":"DL Abeyawardhane","year":"2018","unstructured":"Abeyawardhane DL, Fern\u00e1ndez RD, Murgas CJ et al (2018) Iron redox chemistry promotes antiparallel oligomerization of alpha-synuclein. J Am Chem Soc 140:5028\u20135032","journal-title":"J Am Chem Soc"},{"key":"11_CR70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","volume":"67","author":"Y Porat","year":"2006","unstructured":"Porat Y, Abramowitz A, Gazit E (2006) Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 67:27\u201337","journal-title":"Chem Biol Drug Des"},{"key":"11_CR71","first-page":"535","volume":"30","author":"E Bagli","year":"2016","unstructured":"Bagli E, Goussia A, Moschos MM et al (2016) Natural compounds and neuroprotection: mechanisms of action and novel delivery systems. In Vivo 30:535\u2013547","journal-title":"In Vivo"},{"key":"11_CR72","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41598-017-18807-8","volume":"8","author":"A Franko","year":"2018","unstructured":"Franko A, Camargo DCR, B\u00f6ddrich A et al (2018) Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice. Sci Rep 8:1116","journal-title":"Sci Rep"},{"key":"11_CR73","doi-asserted-by":"publisher","first-page":"23212","DOI":"10.1074\/jbc.M113.464222","volume":"288","author":"M Sato","year":"2013","unstructured":"Sato M, Murakami K, Uno M et al (2013) Site-specific inhibitory mechanism for amyloid beta42 aggregation by catechol-type flavonoids targeting the Lys residues. J Biol Chem 288:23212\u201323224","journal-title":"J Biol Chem"},{"key":"11_CR74","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/ijms11010014","volume":"11","author":"T Tanaka","year":"2010","unstructured":"Tanaka T, Matsuo Y, Kouno I (2010) Chemistry of secondary polyphenols produced during processing of tea and selected foods. Int J Mol Sci 11:14\u201340","journal-title":"Int J Mol Sci"},{"key":"11_CR75","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/cbdd.12552","volume":"86","author":"PP Rao","year":"2015","unstructured":"Rao PP, Mohamed T, Teckwani K et al (2015) Curcumin binding to beta amyloid: a computational study. Chem Biol Drug Des 86:813\u2013820","journal-title":"Chem Biol Drug Des"},{"key":"11_CR76","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3109\/13506129.2010.530008","volume":"17","author":"M Daval","year":"2010","unstructured":"Daval M, Bedrood S, Gurlo T et al (2010) The effect of curcumin on human islet amyloid polypeptide misfolding and toxicity. Amyloid 17:118\u2013128","journal-title":"Amyloid"},{"key":"11_CR77","doi-asserted-by":"publisher","first-page":"33076","DOI":"10.1038\/srep33076","volume":"6","author":"Y Mo","year":"2016","unstructured":"Mo Y, Lei J, Sun Y et al (2016) Conformational ensemble of hIAPP dimer: insight into the molecular mechanism by which a green tea extract inhibits hIAPP aggregation. Sci Rep 6:33076","journal-title":"Sci Rep"},{"key":"11_CR78","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbrc.2016.11.083","volume":"482","author":"JF Aitken","year":"2017","unstructured":"Aitken JF, Loomes KM, Riba-garcia I et al (2017) Rutin suppresses human-amylin\/hIAPP misfolding and oligomer formation in-vitro, and ameliorates diabetes and its impacts in human-amylin\/hIAPP transgenic mice. Biochem Biophys Res Commun 482:625\u2013631","journal-title":"Biochem Biophys Res Commun"},{"key":"11_CR79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1021\/jp507529f","volume":"119","author":"Q Wang","year":"2014","unstructured":"Wang Q, Ning L, Niu Y et al (2014) Molecular mechanism of the inhibition and remodeling of human islet amyloid polypeptide (hIAPP1\u201337) oligomer by resveratrol from molecular dynamics simulation. J Phys Chem B 119:15\u201324","journal-title":"J Phys Chem B"},{"key":"11_CR80","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1039\/c2np20012k","volume":"29","author":"M Gersch","year":"2012","unstructured":"Gersch M, Kreuzer J, Sieber SA (2012) Electrophilic natural products and their biological targets. Nat Prod Rep 29:659\u2013682","journal-title":"Nat Prod Rep"},{"key":"11_CR81","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1021\/acs.biochem.6b00578","volume":"55","author":"P Velander","year":"2016","unstructured":"Velander P, Wu L, Ray WK et al (2016) Amylin amyloid inhibition by flavonoid baicalein: key roles of its vicinal dihydroxyl groups of the catechol moiety. Biochemistry 55:4255\u20134258","journal-title":"Biochemistry"},{"key":"11_CR82","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.2337\/db15-1633","volume":"65","author":"TP Herbert","year":"2016","unstructured":"Herbert TP, Laybutt DR (2016) A reevaluation of the role of the unfolded protein response in islet dysfunction: maladaptation or a failure to adapt? Diabetes 65:1472\u20131480","journal-title":"Diabetes"},{"key":"11_CR83","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41419-018-0533-x","volume":"9","author":"MG Hernandez","year":"2018","unstructured":"Hernandez MG, Aguilar AG, Burillo J et al (2018) Pancreatic beta cells overexpressing hIAPP impaired mitophagy and unbalanced mitochondrial dynamics. Cell Death Dis 9:481","journal-title":"Cell Death Dis"},{"key":"11_CR84","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.redox.2013.12.005","volume":"2","author":"E Borchi","year":"2014","unstructured":"Borchi E, Bargelli V, Guidotti V et al (2014) Mild exposure of RIN-5F beta-cells to human islet amyloid polypeptide aggregates upregulates antioxidant enzymes via NADPH oxidase-RAGE: an hormetic stimulus. Redox Biol 2:114\u2013122","journal-title":"Redox Biol"},{"key":"11_CR85","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41419-017-0135-z","volume":"9","author":"CMO Volpe","year":"2018","unstructured":"Volpe CMO, Villar-Delfino PH, dos Anjos PMF et al (2018) Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis 9:119","journal-title":"Cell Death Dis"},{"key":"11_CR86","first-page":"849017","volume":"2015","author":"M Gao","year":"2015","unstructured":"Gao M, Winter R (2015) The effects of lipid membranes, crowding and osmolytes on the aggregation, and fibrillation propensity of human IAPP. J Diabetes Res 2015:849017","journal-title":"J Diabetes Res"},{"key":"11_CR87","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1039\/C8CC01132J","volume":"54","author":"MFM Sciacca","year":"2018","unstructured":"Sciacca MFM, Monaco I, La Rosa C et al (2018) The active role of Ca(2+) ions in Abeta-mediated membrane damage. Chem Commun 54:3629\u20133631","journal-title":"Chem Commun"},{"key":"11_CR88","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1021\/acs.biochem.7b00199","volume":"56","author":"L Wu","year":"2017","unstructured":"Wu L, Velander P, Liu D et al (2017) Olive component oleuropein promotes beta-cell insulin secretion and protects beta-cells from amylin amyloid-induced cytotoxicity. Biochemist 56:5035\u20135039","journal-title":"Biochemist"},{"key":"11_CR89","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.ejmech.2015.01.047","volume":"92","author":"F Lolicato","year":"2015","unstructured":"Lolicato F, Raudino A, Milardi D et al (2015) Resveratrol interferes with the aggregation of membrane-bound human-IAPP: a molecular dynamics study. Eur J Med Chem 92:876\u2013881","journal-title":"Eur J Med Chem"},{"key":"11_CR90","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.febslet.2014.11.026","volume":"589","author":"HJ Wobst","year":"2015","unstructured":"Wobst HJ, Sharma A, Diamond MI et al (2015) The green tea polyphenol (-)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios. FEBS Lett 589:77\u201383","journal-title":"FEBS Lett"},{"key":"11_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bpc.2012.05.003","volume":"168\u2013169","author":"S Chakraborty","year":"2012","unstructured":"Chakraborty S, Chatterjee B, Basu S (2012) A mechanistic insight into the amyloidogenic structure of hIAPP peptide revealed from sequence analysis and molecular dynamics simulation. Biophys Chem 168\u2013169:1\u20139","journal-title":"Biophys Chem"},{"key":"11_CR92","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.1073\/pnas.93.14.7283","volume":"93","author":"J Janson","year":"1996","unstructured":"Janson J, Soeller WC, Roche PC et al (1996) Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. PNAS 93:7283\u20137288","journal-title":"PNAS"},{"key":"11_CR93","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1743-7075-9-11","volume":"9","author":"H Ortsater","year":"2012","unstructured":"Ortsater H, Grankvist N, Wolfram S et al (2012) Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db\/db mice. Nutr Metab 9:11","journal-title":"Nutr Metab"},{"key":"11_CR94","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ejphar.2011.08.033","volume":"670","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Ding Y, Dai X et al (2011) Epigallocatechin-3-gallate protects pro-inflammatory cytokine induced injuries in insulin-producing cells through the mitochondrial pathway. Eur J Pharmacol 670:311\u2013316","journal-title":"Eur J Pharmacol"},{"key":"11_CR95","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1749-6632.2010.05844.x","volume":"1215","author":"T Szkudelski","year":"2011","unstructured":"Szkudelski T, Szkudelska K (2011) Anti-diabetic effects of resveratrol. Ann N Y Acad Sci 1215:34\u201339","journal-title":"Ann N Y Acad Sci"},{"key":"11_CR96","doi-asserted-by":"publisher","first-page":"e50412","DOI":"10.1371\/journal.pone.0050412","volume":"7","author":"YE Lee","year":"2012","unstructured":"Lee YE, Kim JW, Lee EM et al (2012) Chronic resveratrol treatment protects pancreatic islets against oxidative stress in db\/db mice. PLoS One 7:e50412","journal-title":"PLoS One"},{"key":"11_CR97","doi-asserted-by":"publisher","first-page":"e0218561","DOI":"10.1371\/journal.pone.0218561","volume":"14","author":"N Schultz","year":"2019","unstructured":"Schultz N, Janelidze S, Byman E et al (2019) Levels of islet amyloid polypeptide in cerebrospinal fluid and plasma from patients with Alzheimer\u2019s disease. PLoS One 14:e0218561","journal-title":"PLoS One"}],"container-title":["Advances in Experimental Medicine and Biology","Biomimicked Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-15-3262-7_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T05:05:52Z","timestamp":1649826352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-15-3262-7_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9789811532610","9789811532627"],"references-count":97,"URL":"https:\/\/doi.org\/10.1007\/978-981-15-3262-7_11","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"30 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}